Mori N, Hamada H, Nakamura T, Tanaka A, Nakajima I, Nakamura Y, Wada T, Yasutomi M
First Dept. of Surgery, Kinki University School of Medicine.
Gan To Kagaku Ryoho. 1989 Oct;16(10):3473-6.
A combined therapy with OK-432. mitomycin C (MMC) and 5-fluorouracil (5-FU) by administration through hepatic arterial infusion was performed in three patients with liver metastasis from gastric cancers. A catheter was introduced into hepatic artery by laparotomy. The dosage was 250 mg/day for 5-FU continuously, 10 mg/week for MMC and 5 KE/week for OK-432, respectively. Two cases with advanced gastric cancer and synchronous hepatic metastasis were treated by hepatic arterial infusion after surgical removal of primary lesion. Metastatic lesion in liver was completely eliminated. Another case with metastatic liver tumor from gastric cancer was also treated by the same protocol. The reduction rate of this case was 70% by CT scan. These results suggested that combined therapy with OK-432, MMC and 5-FU by hepatic arterial infusion is a good modality for liver metastases from gastric cancers.
对3例胃癌肝转移患者采用通过肝动脉灌注给予溶链菌制剂、丝裂霉素C(MMC)和5-氟尿嘧啶(5-FU)的联合治疗。通过剖腹手术将导管插入肝动脉。剂量分别为5-FU持续250mg/天,MMC 10mg/周,溶链菌制剂5KE/周。2例晚期胃癌并同时性肝转移患者在手术切除原发灶后接受肝动脉灌注治疗。肝脏转移灶被完全清除。另一例胃癌肝转移瘤患者也采用相同方案治疗。经CT扫描,该病例的缩小率为70%。这些结果表明,通过肝动脉灌注给予溶链菌制剂、MMC和5-FU的联合治疗是胃癌肝转移的一种良好治疗方式。